318 related articles for article (PubMed ID: 25023608)
1. Manzamine alkaloids as antileishmanial agents: A review.
Ashok P; Lathiya H; Murugesan S
Eur J Med Chem; 2015 Jun; 97():928-36. PubMed ID: 25023608
[TBL] [Abstract][Full Text] [Related]
2. Alkaloids: future prospective to combat leishmaniasis.
Mishra BB; Kale RR; Singh RK; Tiwari VK
Fitoterapia; 2009 Mar; 80(2):81-90. PubMed ID: 19015012
[TBL] [Abstract][Full Text] [Related]
3. Current approaches to discover marine antileishmanial natural products.
Tempone AG; Martins de Oliveira C; Berlinck RG
Planta Med; 2011 Apr; 77(6):572-85. PubMed ID: 21243582
[TBL] [Abstract][Full Text] [Related]
4. Marine Algae as Source of Novel Antileishmanial Drugs: A Review.
Tchokouaha Yamthe LR; Appiah-Opong R; Tsouh Fokou PV; Tsabang N; Fekam Boyom F; Nyarko AK; Wilson MD
Mar Drugs; 2017 Oct; 15(11):. PubMed ID: 29109372
[TBL] [Abstract][Full Text] [Related]
5. A pyrimidine-beta-carboline and other alkaloids from Annona foetida with antileishmanial activity.
Costa EV; Pinheiro ML; Xavier CM; Silva JR; Amaral AC; Souza AD; Barison A; Campos FR; Ferreira AG; Machado GM; Leon LL
J Nat Prod; 2006 Feb; 69(2):292-4. PubMed ID: 16499336
[TBL] [Abstract][Full Text] [Related]
6. Preparation and antiprotozoal evaluation of promising β-carboline alkaloids.
Gellis A; Dumètre A; Lanzada G; Hutter S; Ollivier E; Vanelle P; Azas N
Biomed Pharmacother; 2012 Jul; 66(5):339-47. PubMed ID: 22397756
[TBL] [Abstract][Full Text] [Related]
7. [Canine leishmaniasis: evolution of the chemotherapeutic protocols].
Oliva G; Foglia Manzillo V; Pagano A
Parassitologia; 2004 Jun; 46(1-2):231-4. PubMed ID: 15305724
[TBL] [Abstract][Full Text] [Related]
8. Structure activity relationship studies on antileishmanial steroidal alkaloids from Sarcococca hookeriana.
Devkota KP; Choudhary MI; Ranjit R; Samreen ; Sewald N
Nat Prod Res; 2007 Apr; 21(4):292-7. PubMed ID: 17479416
[TBL] [Abstract][Full Text] [Related]
9. Medicinal plants from the Brazilian Amazonian region and their antileishmanial activity: a review.
Da Silva BJM; Hage AAP; Silva EO; Rodrigues APD
J Integr Med; 2018 Jul; 16(4):211-222. PubMed ID: 29691188
[TBL] [Abstract][Full Text] [Related]
10. Miltefosine--discovery of the antileishmanial activity of phospholipid derivatives.
Croft SL; Engel J
Trans R Soc Trop Med Hyg; 2006 Dec; 100 Suppl 1():S4-8. PubMed ID: 16904717
[TBL] [Abstract][Full Text] [Related]
11. Limitations of Current Therapeutic Options, Possible Drug Targets and Scope of Natural Products in Control of Leishmaniasis.
Tiwari N; Gedda MR; Tiwari VK; Singh SP; Singh RK
Mini Rev Med Chem; 2018; 18(1):26-41. PubMed ID: 28443518
[TBL] [Abstract][Full Text] [Related]
12. Isolation, leishmanicidal evaluation and molecular docking simulations of piperidine alkaloids from Senna spectabilis.
Lacerda RBM; Freitas TR; Martins MM; Teixeira TL; da Silva CV; Candido PA; Oliveira RJ; Júnior CV; Bolzani VDS; Danuello A; Pivatto M
Bioorg Med Chem; 2018 Dec; 26(22):5816-5823. PubMed ID: 30413343
[TBL] [Abstract][Full Text] [Related]
13. Modes of action of Leishmanicidal antimicrobial peptides.
Marr AK; McGwire BS; McMaster WR
Future Microbiol; 2012 Sep; 7(9):1047-59. PubMed ID: 22953706
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of drug action and drug resistance in Leishmania as basis for therapeutic target identification and design of antileishmanial modulators.
Loiseau PM; Bories C
Curr Top Med Chem; 2006; 6(5):539-50. PubMed ID: 16719806
[TBL] [Abstract][Full Text] [Related]
15. Application of nanotechnology in treatment of leishmaniasis: A Review.
Akbari M; Oryan A; Hatam G
Acta Trop; 2017 Aug; 172():86-90. PubMed ID: 28460833
[TBL] [Abstract][Full Text] [Related]
16. Interactions of antiparasitic alkaloids with Leishmania protein targets: a molecular docking analysis.
Ogungbe IV; Ng JD; Setzer WN
Future Med Chem; 2013 Oct; 5(15):1777-99. PubMed ID: 24144413
[TBL] [Abstract][Full Text] [Related]
17. Paromomycin in the treatment of leishmaniasis.
Sundar S; Chakravarty J
Expert Opin Investig Drugs; 2008 May; 17(5):787-94. PubMed ID: 18447603
[TBL] [Abstract][Full Text] [Related]
18. New antileishmanial candidates and lead compounds.
Richard JV; Werbovetz KA
Curr Opin Chem Biol; 2010 Aug; 14(4):447-55. PubMed ID: 20400358
[TBL] [Abstract][Full Text] [Related]
19. Effect of 3-alkylpyridine marine alkaloid analogues in Leishmania species related to American cutaneous leishmaniasis.
Machado PA; Hilário FF; Carvalho LO; Silveira ML; Alves RB; Freitas RP; Coimbra ES
Chem Biol Drug Des; 2012 Nov; 80(5):745-51. PubMed ID: 22882996
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of Thiocarbohydrazones and Evaluation of their in vitro Antileishmanial Activity.
Muhammad MT; Ghouri N; Khan KM; Arshia ; Choudhary MI; Perveen S
Med Chem; 2018; 14(7):725-732. PubMed ID: 29332596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
